Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams

Veterinary Research

Volumn 27, Issue 4-5, 1996, Pages 443-452

  Monteil, M ^a   Le Potier, M F ^b   Guillotin, J ^c   Cariolet, R ^b   Houdayer, C ^b   Eloit M ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

^c Domaine du Certia   (France)

Author keywords

Antibody response; Genetic immunization; Protection; Pseudorabies virus; Vaccine

Indexed keywords

SUID HERPESVIRUS 1;

PSEUDORABIES VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ANTIBODY PRODUCTION; ARTICLE; BIOSYNTHESIS; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY; MOUSE; MOUSE STRAIN; NEWBORN; PASSIVE IMMUNIZATION; PLASMID; PREGNANCY; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; SWINE; VACCINATION; VIRUS GENE;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; GENES, VIRAL; HERPESVIRUS 1, SUID; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; KIDNEY; MICE; MICE, INBRED STRAINS; PLASMIDS; PREGNANCY; PSEUDORABIES; PSEUDORABIES VACCINES; SWINE; TRANSFECTION; VACCINATION; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0030348242     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Adam M, Le Pottier MF, Eloit M (1994) Vaccination of pigs with replication-defective adenovirus-vectored vaccine: the example of pseudorabies Vet Microbiol 42, 205-215
2. Coe NE, Mengeling WL (1990) Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus. Arch Virol 110, 137-142
3. Coney L, Wang B, Ugen KE et al (1994) Facilitated DNA inoculation induces anti-HIV1 immunity in vivo. Vaccine 12, 1545-1550
4. Danko I, Wolff JA (1994) Direct gene transfer into muscle. Vaccine 12, 1499-1502
5. Eloit M, Fargeaud D, L'Haridon R, Toma B (1988) Identification of pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Arch. Virol 99, 45-56
6. Eloit M, Gilardi-Hebenstreit P, Toma B, Perricaudet M (1990) Construction of a defective adenovirus vector expressing the pseudorabies virus gp50 and its use as a live vaccine, J Gen Virol 71, 2425-2431
7. Ganne V, Eloit M, Laval A, Adam M, Trouve G (1994) Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants. Vaccine 12, 1190-1196
8. Haddada E, Lopez M, Martinache C, Ragot T, Abina MA, Perncaudet M, (1993) Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. Biochem Biophys Res Commun 3, 1174-1183
9. Ishii H, Kobayashi Y, Kuroki M, Kodama Y (1988) Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. J Gen Virol 69, 1411-1414
10. Lowrie DB, Tascon RE, Colston MJ, Silva CL (1994) Towards a DNA vaccine against tuberculosis. Vaccine, 12, 1537-1540
11. Marchioli C, Yancey R, Petrovskis E, Timmins J, Post L (1987) Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. J Virol 61, 3977-3982
12. Peeters B, Pol J, Gielkens A, Moormann R (1993) Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice, J Virol 67, 170-177
13. Raugh LF, Mettenleiter TC (1991) Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol 65, 5348-5356
14. Riviere M, Tartaglia J, Perkus M, Norton E, Bongermino C, Lacoste F, Duret C, Desmettre P, Paoletti E (1992) Protection of mice and swine from pseudorabies virus by vaccinia virus-based recombinants. J Virol 66, 3424-3434
15. Stellmann C, Vannier P, Chappuis G, Brun A, Dauvergne M, Fargeaud D, Bugand M, Colson X (1989) The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J Biol Stand 17, 17-27
16. Ulmer JB, Donelly J, Parker SE (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749
17. Ulmer JB, Deck RR, DeWitt CM, Friedman A, Donnelly JJ, Liu MA (1994) Protection immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12, 1541-1544
18. Vannier P, Hutet E, Bourgueil E, Cariolet R. (1991) Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines. Vet Microbiol 29, 211-223
19. Wathen MW, Wathen LMK (1984) Isolation, characterisation and physical mapping of a pseudorabies virus mutant containing antigenically-altered gp50. J Virol 51, 57-62
20. Xu D, Liew FY (1994) Genetic vaccination against leishmaniasis. Vaccine 12, 1534-1536